DE69334134D1 - Wässrige Formulierung enthaltend Menschliches Wachstumshormon - Google Patents

Wässrige Formulierung enthaltend Menschliches Wachstumshormon

Info

Publication number
DE69334134D1
DE69334134D1 DE69334134T DE69334134T DE69334134D1 DE 69334134 D1 DE69334134 D1 DE 69334134D1 DE 69334134 T DE69334134 T DE 69334134T DE 69334134 T DE69334134 T DE 69334134T DE 69334134 D1 DE69334134 D1 DE 69334134D1
Authority
DE
Germany
Prior art keywords
growth hormone
formulation containing
human growth
aqueous formulation
containing human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69334134T
Other languages
English (en)
Other versions
DE69334134T2 (de
Inventor
Barbara H Connor
James Eswein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25448638&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69334134(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of DE69334134D1 publication Critical patent/DE69334134D1/de
Application granted granted Critical
Publication of DE69334134T2 publication Critical patent/DE69334134T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH] (Somatotropin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
DE69334134T 1992-07-31 1993-07-29 Wässrige Formulierung enthaltend Menschliches Wachstumshormon Expired - Lifetime DE69334134T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92340192A 1992-07-31 1992-07-31
US923401 1992-07-31

Publications (2)

Publication Number Publication Date
DE69334134D1 true DE69334134D1 (de) 2007-05-31
DE69334134T2 DE69334134T2 (de) 2007-12-20

Family

ID=25448638

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69334134T Expired - Lifetime DE69334134T2 (de) 1992-07-31 1993-07-29 Wässrige Formulierung enthaltend Menschliches Wachstumshormon
DE69329651T Expired - Lifetime DE69329651T3 (de) 1992-07-31 1993-07-29 Wässrige arzneizusammensetzung, welche das menschliche wachstumshormon enthält

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69329651T Expired - Lifetime DE69329651T3 (de) 1992-07-31 1993-07-29 Wässrige arzneizusammensetzung, welche das menschliche wachstumshormon enthält

Country Status (15)

Country Link
EP (2) EP0652766B2 (de)
JP (2) JP4018133B2 (de)
AT (2) ATE197405T1 (de)
AU (1) AU686567C (de)
CA (3) CA2337745C (de)
DE (2) DE69334134T2 (de)
DK (2) DK0652766T4 (de)
ES (2) ES2286868T3 (de)
GR (1) GR3035144T3 (de)
IL (1) IL106524A (de)
MD (1) MD1699F2 (de)
MX (1) MX9304613A (de)
NZ (1) NZ255158A (de)
PT (1) PT652766E (de)
WO (1) WO1994003198A1 (de)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763394A (en) * 1988-04-15 1998-06-09 Genentech, Inc. Human growth hormone aqueous formulation
US5981485A (en) 1997-07-14 1999-11-09 Genentech, Inc. Human growth hormone aqueous formulation
US5849704A (en) * 1991-12-20 1998-12-15 Novo Nordisk A/S Pharmaceutical formulation
US5849700A (en) * 1991-12-20 1998-12-15 Novo Nordisk A/S Pharmaceutical formulation
DK204791D0 (da) * 1991-12-20 1991-12-20 Novo Nordisk As Hidtil ukendt farmaceutisk praeparat
US6022858A (en) * 1991-12-20 2000-02-08 Novo Nordisk A/S Pharmaceutical formulation of human-growth hormone pretreated with zinc salt
SE9201073D0 (sv) * 1992-04-03 1992-04-03 Kabi Pharmacia Ab Protein formulation
US5877016A (en) 1994-03-18 1999-03-02 Genentech, Inc. Human trk receptors and neurotrophic factor inhibitors
DE69420872T2 (de) * 1994-06-17 2000-01-13 Applied Research Systems Hgh enthaltende pharmazeutische zubereitungen
US5631225A (en) * 1994-10-13 1997-05-20 Novo Nordisk A/S Pharmaceutical formulation
US5547696A (en) * 1994-10-13 1996-08-20 Novo Nordisk A/S Pharmaceutical formulation
US5654278A (en) * 1994-10-13 1997-08-05 Novo Nordisk A/S Composition and method comprising growth hormone and leucine
US5705482A (en) * 1995-01-13 1998-01-06 Novo Nordisk A/S Pharmaceutical formulation
US5552385A (en) * 1995-06-05 1996-09-03 Novo Nordisk A/S Pharmaceutical formulation
US6790439B1 (en) * 1995-06-07 2004-09-14 Zymogenetics, Inc. Thrombopoietin compositions
US6267958B1 (en) 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
SE9502927D0 (sv) * 1995-08-24 1995-08-24 Pharmacia Ab Solution containing IGF-I
GB9526733D0 (en) 1995-12-30 1996-02-28 Delta Biotechnology Ltd Fusion proteins
AUPN801296A0 (en) 1996-02-12 1996-03-07 Csl Limited Stabilised growth hormone formulation and method of preparation thereof
US20070179096A1 (en) 1996-04-24 2007-08-02 Novo Nordisk A/S Pharmaceutical Formulation
US20020077461A1 (en) * 1996-04-24 2002-06-20 Soren Bjorn Pharmaceutical formulation
SE9704405D0 (sv) * 1997-11-28 1997-11-28 Pharmacia & Upjohn Ab New syringe
JP3723857B2 (ja) * 1998-02-04 2005-12-07 日本ケミカルリサーチ株式会社 ヒト成長ホルモン含有水性医薬組成物
PL346127A1 (en) * 1998-07-23 2002-01-28 Lilly Co Eli Fsh and fsh variant formulations, products and methods
US20030166525A1 (en) 1998-07-23 2003-09-04 Hoffmann James Arthur FSH Formulation
TR200200034T2 (tr) * 1999-07-12 2002-05-21 Grandis Biotech Gmbh Büyüme hormonu formülasyonları.
CA2747325A1 (en) 2000-04-12 2001-10-25 Human Genome Sciences, Inc. Albumin fusion proteins
WO2001087322A2 (en) * 2000-05-17 2001-11-22 Bionebraska, Inc. Peptide pharmaceutical formulations
GB2371227A (en) * 2001-01-10 2002-07-24 Grandis Biotech Gmbh Crystallisation - resistant aqueous growth hormone formulations
ES2425738T3 (es) 2001-12-21 2013-10-17 Human Genome Sciences, Inc. Proteínas de fusión de la albúmina
US20080194481A1 (en) 2001-12-21 2008-08-14 Human Genome Sciences, Inc. Albumin Fusion Proteins
WO2004004780A1 (en) * 2002-07-09 2004-01-15 Sandoz Ag Liquid formulations with high concentration of human growth hormone (hgh) comprising phenol
CA2512052C (en) 2002-12-31 2016-06-21 Altus Pharmaceuticals Inc. Human growth hormone crystals and methods for preparing them
MXPA05010635A (es) 2003-04-02 2005-12-12 Ares Trading Sa Formulaciones farmaceuticas liquidas de hormona estimulante de foliculos y hormona luteinizante junto con un surfactante no ionico.
EP1638595B1 (de) 2003-06-20 2013-03-20 Ares Trading S.A. Gefriergetrocknete fsh / lh formulierungen
EP1706150B1 (de) * 2003-12-23 2012-04-25 Pharmacia Corporation Stabiles Wachstumshormon-Flüssigformulierung
MXPA06009072A (es) 2004-02-09 2007-03-29 Human Genome Sciences Inc Proteinas de fusion de albumina.
WO2005105148A2 (en) * 2004-04-07 2005-11-10 Ares Trading S.A.- Liquid growth hormone formulation
AU2007258609B2 (en) 2006-06-07 2013-01-24 Human Genome Sciences, Inc. Albumin fusion proteins
BRPI0621841B8 (pt) 2006-07-06 2021-05-25 Daewoong Co Ltd formulação líquida
DK2486916T3 (en) * 2006-12-18 2015-06-15 Ajinomoto Althea Inc Formulations of Human Growth Hormone
US8283333B2 (en) 2009-07-01 2012-10-09 Protiva Biotherapeutics, Inc. Lipid formulations for nucleic acid delivery
KR101614983B1 (ko) * 2009-11-17 2016-04-22 입센 파마 에스.에이.에스 Ｈｇｈ 및 ｒｈｉｇｆ―１의 조합물을 위한 제제
TWI508737B (zh) 2010-01-22 2015-11-21 諾佛 儂迪克股份有限公司 具有延長的活體內功效的生長激素
RU2012134974A (ru) 2010-01-22 2014-02-27 Ново Нордиск Хелс Кеа Аг Стабилизированное соединение гормона роста
WO2012000104A1 (en) 2010-06-30 2012-01-05 Protiva Biotherapeutics, Inc. Non-liposomal systems for nucleic acid delivery
KR101337797B1 (ko) * 2010-07-14 2013-12-06 한미사이언스 주식회사 지속형 인간 성장 호르몬 결합체 액상 제제
WO2013014196A1 (en) * 2011-07-25 2013-01-31 Sandoz Ag Aqueous formulation comprising at least a neutral salt and a biopharmaceutical protein
US10064951B2 (en) * 2012-03-30 2018-09-04 Hanmi Science Co., Ltd. Liquid formulation of highly concentrated long-acting human growth hormone conjugate
JP5487276B2 (ja) * 2012-11-12 2014-05-07 デウン カンパニー，リミテッド ヒト成長ホルモンを含有する安定した液状製剤
ES2841123T3 (es) * 2013-04-05 2021-07-07 Formulacion Del Compuesto De La Hormona De Crecimiento Formulación del compuesto de la hormona de crecimiento
CN113425835B (zh) * 2020-03-23 2024-03-19 常州健益生物制药有限公司 一种生长激素原料药溶液、水针剂及其制备方法
CN112494638B (zh) * 2020-12-22 2023-12-19 深圳科兴药业有限公司 一种人生长激素注射剂组合物及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783441A (en) * 1979-04-30 1988-11-08 Hoechst Aktiengesellschaft Aqueous protein solutions stable to denaturation
DE3325223A1 (de) * 1983-07-13 1985-01-24 Hoechst Ag, 6230 Frankfurt Gegen denaturierung bestaendige, waessrige proteinloesungen, verfahren zu ihrer herstellung und ihre verwendung
EP0211601A3 (de) 1985-07-30 1988-01-13 International Minerals And Chemical Corporation Stabilisierung von Wachstumshormonen
ES2044941T5 (es) * 1987-08-21 1999-02-16 Mallinckrodt Group Inc Estabilizador de hormonas promotoras del crecimiento.
US5096885A (en) * 1988-04-15 1992-03-17 Genentech, Inc. Human growth hormone formulation
US4904043A (en) * 1988-06-15 1990-02-27 American Telephone And Telegraph Company, At&T Bell Laboratories Optical data link dual wavelength coupler
US5182258A (en) * 1989-03-20 1993-01-26 Orbon Corporation Systemic delivery of polypeptides through the eye
GB9007052D0 (en) * 1990-03-29 1990-05-30 Skua Investments Ltd Pharmaceutical formulations
US5126324A (en) * 1990-06-07 1992-06-30 Genentech, Inc. Method of enhancing growth in patients using combination therapy
US5210017A (en) * 1990-11-19 1993-05-11 Genentech, Inc. Ligand-mediated immunofunctional hormone binding protein assay method

Also Published As

Publication number Publication date
NZ255158A (en) 1997-09-22
GR3035144T3 (en) 2001-04-30
EP0955062A1 (de) 1999-11-10
PT652766E (pt) 2001-04-30
CA2139358A1 (en) 1994-02-17
ES2286868T3 (es) 2007-12-01
MD1699F2 (ro) 2001-07-31
WO1994003198A1 (en) 1994-02-17
DK0955062T3 (da) 2007-09-17
DK0652766T3 (da) 2001-01-29
ATE359824T1 (de) 2007-05-15
CA2337745C (en) 2005-04-12
DK0652766T4 (da) 2008-06-09
MD960246A (en) 1998-01-31
DE69329651T3 (de) 2008-10-30
CA2337745A1 (en) 1994-02-17
ATE197405T1 (de) 2000-11-11
AU4792793A (en) 1994-03-03
CA2139358C (en) 2001-02-13
DE69329651D1 (de) 2000-12-14
JP2007045841A (ja) 2007-02-22
EP0652766A1 (de) 1995-05-17
CA2489978A1 (en) 1994-02-17
ES2153385T5 (es) 2008-09-01
ES2153385T3 (es) 2001-03-01
JP4018133B2 (ja) 2007-12-05
EP0652766B1 (de) 2000-11-08
EP0652766B2 (de) 2008-03-19
IL106524A0 (en) 1993-11-15
DE69334134T2 (de) 2007-12-20
AU686567C (en) 2002-08-08
JPH07509719A (ja) 1995-10-26
MX9304613A (es) 1994-03-31
DE69329651T2 (de) 2001-05-23
IL106524A (en) 2000-08-31
AU686567B2 (en) 1998-02-12
EP0955062B1 (de) 2007-04-18

Similar Documents

Publication Publication Date Title
DK0955062T3 (da) Vandig formulering indeholdende humant væksthormon
FI933393A0 (fi) Agglomererade hydrofila komplex med flerfasiga frigoeringsegenskaper
IL126463A0 (en) A pharmaceutical formulation containing growth hormone an amino acid and a non-ionic detergent
CZ307715A3 (cs) Způsob lyofilizace vodné farmaceutické formulace faktoru VIII prosté albuminu
ATE203411T1 (de) Lagerstabile wässrige pharmazeutische zubereitungen von g-csf
MX9710206A (es) Composicion farmaceutica de amiodarone para administracion parenteral.
CA2226548A1 (en) Lyophilized hepatocyte growth factor preparations
GR3032546T3 (en) Use of azoles as virucidal agents in solutions of biologically active proteins
ES2138053T3 (es) Formulacion insecticida solida.
DK248987A (da) Farmaceutiske praeparater til forbedring af sammensaetningen af lipider i blod
KR950700743A (ko) 프로스타사이클린류를 활성성분으로서 함유하는 외용 피부치료제 조성물(dermatologic preparation composition containing prostacyclin as active ingredient)
FI880027A (fi) Antibakteriellt lyofiliserat preparat.
SE8400971L (sv) Profylaktiskt och lekande medel for arterioskleros
GB2021581A (en) Stabilisation of PGl2 derivatives
EP0509098A4 (en) Ataractic
EP0456988A3 (en) Use of naproxen as mydriatic agent
ITMI920760U1 (it) Struttura di utensile del tipo fresca o simile particolarmente per l'esecuzione di interventi chirurgici di implantollogia odontoiatrica
IT1255237B (it) Composizione farmaceuticaidrofila ad attivita' antiinfiammatoria

Legal Events

Date Code Title Description
8363 Opposition against the patent